investorscraft@gmail.com

Intrinsic ValueCross Country Healthcare, Inc. (CCRN)

Previous Close$12.55
Intrinsic Value
Upside potential
Previous Close
$12.55

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Cross Country Healthcare, Inc. operates as a leading workforce solutions and staffing firm specializing in healthcare. The company provides flexible staffing solutions, including travel nursing, per diem staffing, and permanent placement services, catering to hospitals, clinics, and other healthcare facilities. Its revenue model is driven by contract labor placements, where it earns fees based on the duration and skill level of the healthcare professionals it supplies. The healthcare staffing industry is highly competitive and cyclical, influenced by labor shortages, regulatory changes, and healthcare demand fluctuations. Cross Country differentiates itself through its national scale, deep industry relationships, and technology-driven recruitment platforms. The company holds a strong position in the travel nursing segment, which remains a critical revenue driver amid persistent nurse shortages. Its ability to quickly adapt to market needs and maintain a robust candidate pipeline supports its competitive edge.

Revenue Profitability And Efficiency

Cross Country Healthcare reported revenue of $1.34 billion for FY 2024, reflecting its scale in the healthcare staffing sector. However, the company posted a net loss of $14.6 million, with diluted EPS of -$0.44, indicating margin pressures. Operating cash flow stood at $120.1 million, demonstrating solid cash generation despite profitability challenges. Capital expenditures were modest at $8.7 million, suggesting disciplined investment in growth.

Earnings Power And Capital Efficiency

The company’s negative net income highlights earnings volatility, likely tied to labor cost inflation or contract pricing dynamics. Operating cash flow remains healthy, supporting liquidity. With minimal debt ($3.9 million) and $81.6 million in cash, Cross Country maintains a strong liquidity position, allowing flexibility to navigate cyclical demand shifts.

Balance Sheet And Financial Health

Cross Country’s balance sheet is robust, with cash and equivalents of $81.6 million and negligible debt, yielding a net cash position. This conservative leverage profile provides resilience against industry downturns. The absence of dividends suggests a focus on reinvestment or strategic flexibility.

Growth Trends And Dividend Policy

Revenue trends reflect demand for healthcare staffing, though profitability remains inconsistent. The company does not pay dividends, prioritizing operational reinvestment or potential M&A. Growth hinges on addressing labor shortages and expanding service offerings in high-demand specialties.

Valuation And Market Expectations

The market likely prices Cross Country based on cyclical recovery potential in healthcare staffing. Negative earnings may weigh on valuation multiples, but strong cash flow and a clean balance sheet could support investor confidence in long-term positioning.

Strategic Advantages And Outlook

Cross Country’s national footprint and technology-driven recruitment provide scalability. Persistent healthcare labor shortages underpin demand, but profitability improvement depends on cost management and pricing power. The outlook remains cautiously optimistic, contingent on industry dynamics and execution.

Sources

Company filings (10-K), financial statements

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount